INCORPORATING	O
ENVIRONMENTAL	B:C0014406

OUTCOMES	O
INTO	O
A	O
HEALTH	O
ECONOMIC	B:C0013554
MODEL	I:C0013554
.	O

Traditional	O
economic	O
evaluations	O
for	O
most	O
health	B:C0039423
technology	I:C0039423
assessments	I:C0039423
(	O
health	O
technology	I:C0039423
assessments	I:C0039423
)	O
have	O
previously	O
not	O
included	O
environmental	O
outcomes	O
.	O

Traditional	O
economic	O
evaluations	O
for	O
most	O
health	O
technology	I:C0039423
assessments	I:C0039423
(	O
health	B:C0039423
technology	I:C0039423
assessments	I:C0039423
)	O
have	O
previously	O
not	O
included	O
environmental	O
outcomes	O
.	O

Traditional	O
economic	O
evaluations	O
for	O
most	O
health	O
technology	I:C0039423
assessments	I:C0039423
(	O
health	O
technology	I:C0039423
assessments	I:C0039423
)	O
have	O
previously	O
not	O
included	O
environmental	B:C0014406
outcomes	O
.	O

With	O
the	O
growing	O
interest	O
in	O
reducing	O
the	O
environmental	O
impact	O
of	O
human	O
activities	O
,	O
the	O
need	O
to	O
consider	O
how	O
to	O
include	O
environmental	B:C0014406
outcomes	O
into	O
health	O
technology	I:C0039423
assessments	I:C0039423
has	O
increased	O
.	O

With	O
the	O
growing	O
interest	O
in	O
reducing	O
the	O
environmental	O
impact	O
of	O
human	O
activities	O
,	O
the	O
need	O
to	O
consider	O
how	O
to	O
include	O
environmental	O
outcomes	O
into	O
health	B:C0039423
technology	I:C0039423
assessments	I:C0039423
has	O
increased	O
.	O

We	O
adapted	O
an	O
existing	O
clinical	O
-	O
economic	B:C0013554
model	I:C0013554
to	O
include	O
environmental	O
outcomes	O
(	O
carbon	O
dioxide	I:C0007012
[	O
CO2	O
]	O
emissions	O
)	O
to	O
predict	O
the	O
consequences	O
of	O
adding	O
insulin	O
to	O
an	O
oral	O
antidiabetic	O
(	O
oral	O
antidiabetic	I:C0935929
)	O
regimen	O
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
)	O
over	O
30	O
years	O
,	O
from	O
the	O
United	O
Kingdom	I:C0041700
payer	O
perspective	O
.	O

We	O
adapted	O
an	O
existing	O
clinical	O
-	O
economic	O
model	I:C0013554
to	O
include	O
environmental	B:C0014406
outcomes	O
(	O
carbon	O
dioxide	I:C0007012
[	O
CO2	O
]	O
emissions	O
)	O
to	O
predict	O
the	O
consequences	O
of	O
adding	O
insulin	O
to	O
an	O
oral	O
antidiabetic	O
(	O
oral	O
antidiabetic	I:C0935929
)	O
regimen	O
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
)	O
over	O
30	O
years	O
,	O
from	O
the	O
United	O
Kingdom	I:C0041700
payer	O
perspective	O
.	O

We	O
adapted	O
an	O
existing	O
clinical	O
-	O
economic	O
model	I:C0013554
to	O
include	O
environmental	O
outcomes	O
(	O
carbon	B:C0007012
dioxide	I:C0007012
[	O
CO2	O
]	O
emissions	O
)	O
to	O
predict	O
the	O
consequences	O
of	O
adding	O
insulin	O
to	O
an	O
oral	O
antidiabetic	O
(	O
oral	O
antidiabetic	I:C0935929
)	O
regimen	O
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
)	O
over	O
30	O
years	O
,	O
from	O
the	O
United	O
Kingdom	I:C0041700
payer	O
perspective	O
.	O

We	O
adapted	O
an	O
existing	O
clinical	O
-	O
economic	O
model	I:C0013554
to	O
include	O
environmental	O
outcomes	O
(	O
carbon	O
dioxide	I:C0007012
[	O
CO2	B:C0007012
]	O
emissions	O
)	O
to	O
predict	O
the	O
consequences	O
of	O
adding	O
insulin	O
to	O
an	O
oral	O
antidiabetic	O
(	O
oral	O
antidiabetic	I:C0935929
)	O
regimen	O
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
)	O
over	O
30	O
years	O
,	O
from	O
the	O
United	O
Kingdom	I:C0041700
payer	O
perspective	O
.	O

We	O
adapted	O
an	O
existing	O
clinical	O
-	O
economic	O
model	I:C0013554
to	O
include	O
environmental	O
outcomes	O
(	O
carbon	O
dioxide	I:C0007012
[	O
CO2	O
]	O
emissions	O
)	O
to	O
predict	O
the	O
consequences	O
of	O
adding	O
insulin	B:C0021641
to	O
an	O
oral	O
antidiabetic	O
(	O
oral	O
antidiabetic	I:C0935929
)	O
regimen	O
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
)	O
over	O
30	O
years	O
,	O
from	O
the	O
United	O
Kingdom	I:C0041700
payer	O
perspective	O
.	O

We	O
adapted	O
an	O
existing	O
clinical	O
-	O
economic	O
model	I:C0013554
to	O
include	O
environmental	O
outcomes	O
(	O
carbon	O
dioxide	I:C0007012
[	O
CO2	O
]	O
emissions	O
)	O
to	O
predict	O
the	O
consequences	O
of	O
adding	O
insulin	O
to	O
an	O
oral	B:C0442027
antidiabetic	O
(	O
oral	O
antidiabetic	I:C0935929
)	O
regimen	O
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
)	O
over	O
30	O
years	O
,	O
from	O
the	O
United	O
Kingdom	I:C0041700
payer	O
perspective	O
.	O

We	O
adapted	O
an	O
existing	O
clinical	O
-	O
economic	O
model	I:C0013554
to	O
include	O
environmental	O
outcomes	O
(	O
carbon	O
dioxide	I:C0007012
[	O
CO2	O
]	O
emissions	O
)	O
to	O
predict	O
the	O
consequences	O
of	O
adding	O
insulin	O
to	O
an	O
oral	O
antidiabetic	B:C0935929
(	O
oral	O
antidiabetic	I:C0935929
)	O
regimen	O
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
)	O
over	O
30	O
years	O
,	O
from	O
the	O
United	O
Kingdom	I:C0041700
payer	O
perspective	O
.	O

We	O
adapted	O
an	O
existing	O
clinical	O
-	O
economic	O
model	I:C0013554
to	O
include	O
environmental	O
outcomes	O
(	O
carbon	O
dioxide	I:C0007012
[	O
CO2	O
]	O
emissions	O
)	O
to	O
predict	O
the	O
consequences	O
of	O
adding	O
insulin	O
to	O
an	O
oral	O
antidiabetic	O
(	O
oral	B:C0935929
antidiabetic	I:C0935929
)	O
regimen	O
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
)	O
over	O
30	O
years	O
,	O
from	O
the	O
United	O
Kingdom	I:C0041700
payer	O
perspective	O
.	O

We	O
adapted	O
an	O
existing	O
clinical	O
-	O
economic	O
model	I:C0013554
to	O
include	O
environmental	O
outcomes	O
(	O
carbon	O
dioxide	I:C0007012
[	O
CO2	O
]	O
emissions	O
)	O
to	O
predict	O
the	O
consequences	O
of	O
adding	O
insulin	O
to	O
an	O
oral	O
antidiabetic	O
(	O
oral	O
antidiabetic	I:C0935929
)	O
regimen	B:C0040808
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
)	O
over	O
30	O
years	O
,	O
from	O
the	O
United	O
Kingdom	I:C0041700
payer	O
perspective	O
.	O

We	O
adapted	O
an	O
existing	O
clinical	O
-	O
economic	O
model	I:C0013554
to	O
include	O
environmental	O
outcomes	O
(	O
carbon	O
dioxide	I:C0007012
[	O
CO2	O
]	O
emissions	O
)	O
to	O
predict	O
the	O
consequences	O
of	O
adding	O
insulin	O
to	O
an	O
oral	O
antidiabetic	O
(	O
oral	O
antidiabetic	I:C0935929
)	O
regimen	O
for	O
patients	O
with	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
)	O
over	O
30	O
years	O
,	O
from	O
the	O
United	O
Kingdom	I:C0041700
payer	O
perspective	O
.	O

We	O
adapted	O
an	O
existing	O
clinical	O
-	O
economic	O
model	I:C0013554
to	O
include	O
environmental	O
outcomes	O
(	O
carbon	O
dioxide	I:C0007012
[	O
CO2	O
]	O
emissions	O
)	O
to	O
predict	O
the	O
consequences	O
of	O
adding	O
insulin	O
to	O
an	O
oral	O
antidiabetic	O
(	O
oral	O
antidiabetic	I:C0935929
)	O
regimen	O
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
(	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
)	O
over	O
30	O
years	O
,	O
from	O
the	O
United	O
Kingdom	I:C0041700
payer	O
perspective	O
.	O

We	O
adapted	O
an	O
existing	O
clinical	O
-	O
economic	O
model	I:C0013554
to	O
include	O
environmental	O
outcomes	O
(	O
carbon	O
dioxide	I:C0007012
[	O
CO2	O
]	O
emissions	O
)	O
to	O
predict	O
the	O
consequences	O
of	O
adding	O
insulin	O
to	O
an	O
oral	O
antidiabetic	O
(	O
oral	O
antidiabetic	I:C0935929
)	O
regimen	O
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
)	O
over	O
30	O
years	O
,	O
from	O
the	O
United	B:C0041700
Kingdom	I:C0041700
payer	O
perspective	O
.	O

We	O
adapted	O
an	O
existing	O
clinical	O
-	O
economic	O
model	I:C0013554
to	O
include	O
environmental	O
outcomes	O
(	O
carbon	O
dioxide	I:C0007012
[	O
CO2	O
]	O
emissions	O
)	O
to	O
predict	O
the	O
consequences	O
of	O
adding	O
insulin	O
to	O
an	O
oral	O
antidiabetic	O
(	O
oral	O
antidiabetic	I:C0935929
)	O
regimen	O
for	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
)	O
over	O
30	O
years	O
,	O
from	O
the	O
United	O
Kingdom	I:C0041700
payer	B:C2348942
perspective	O
.	O

Epidemiological	B:C0002783
,	O
efficacy	O
,	O
healthcare	O
costs	O
,	O
utility	O
,	O
and	O
carbon	O
emissions	O
data	O
were	O
derived	O
from	O
published	O
literature	I:C0023866
.	O

Epidemiological	O
,	O
efficacy	B:C1707887
,	O
healthcare	O
costs	O
,	O
utility	O
,	O
and	O
carbon	O
emissions	O
data	O
were	O
derived	O
from	O
published	O
literature	I:C0023866
.	O

Epidemiological	O
,	O
efficacy	O
,	O
healthcare	O
costs	O
,	O
utility	O
,	O
and	O
carbon	B:C0007012
emissions	O
data	O
were	O
derived	O
from	O
published	O
literature	I:C0023866
.	O

Epidemiological	O
,	O
efficacy	O
,	O
healthcare	O
costs	O
,	O
utility	O
,	O
and	O
carbon	O
emissions	O
data	O
were	O
derived	O
from	O
published	B:C0023866
literature	I:C0023866
.	O

A	O
scenario	O
analysis	B:C0936012
was	O
performed	O
to	O
explore	O
the	O
impact	O
of	O
parameter	O
uncertainty	O
.	O

A	O
scenario	O
analysis	O
was	O
performed	O
to	O
explore	O
the	O
impact	O
of	O
parameter	O
uncertainty	B:C0087130
.	O

The	O
addition	O
of	O
insulin	B:C0021641
to	O
an	O
oral	O
antidiabetic	I:C0935929
regimen	O
increases	O
costs	O
by	O
2,668	O
British	O
pounds	O
per	O
patient	O
and	O
is	O
associated	O
with	O
0.36	O
additional	O
quality	O
-	O
adjusted	O
life	O
-	O
years	O
per	O
patient	O
.	O

The	O
addition	O
of	O
insulin	O
to	O
an	O
oral	B:C0935929
antidiabetic	I:C0935929
regimen	O
increases	O
costs	O
by	O
2,668	O
British	O
pounds	O
per	O
patient	O
and	O
is	O
associated	O
with	O
0.36	O
additional	O
quality	O
-	O
adjusted	O
life	O
-	O
years	O
per	O
patient	O
.	O

The	O
addition	O
of	O
insulin	O
to	O
an	O
oral	O
antidiabetic	I:C0935929
regimen	B:C0040808
increases	O
costs	O
by	O
2,668	O
British	O
pounds	O
per	O
patient	O
and	O
is	O
associated	O
with	O
0.36	O
additional	O
quality	O
-	O
adjusted	O
life	O
-	O
years	O
per	O
patient	O
.	O

The	O
insulin	B:C0021641
-	O
oral	O
antidiabetic	I:C0935929
combination	O
regimen	O
generates	O
more	O
treatment	O
and	O
disease	O
management	I:C0376636
-	O
related	O
CO2	O
emissions	O
per	O
patient	O
(	O
1,686	O
kg	O
)	O
than	O
the	O
oral	O
antidiabetic	I:C0935929
-	O
only	O
regimen	O
(	O
310	O
kg	O
)	O
,	O
but	O
generates	O
fewer	O
emissions	O
associated	O
with	O
treating	O
complications	O
(	O
3,019	O
kg	O
versus	O
3,337	O
kg	O
)	O
.	O

The	O
insulin	O
-	O
oral	B:C0935929
antidiabetic	I:C0935929
combination	O
regimen	O
generates	O
more	O
treatment	O
and	O
disease	O
management	I:C0376636
-	O
related	O
CO2	O
emissions	O
per	O
patient	O
(	O
1,686	O
kg	O
)	O
than	O
the	O
oral	O
antidiabetic	I:C0935929
-	O
only	O
regimen	O
(	O
310	O
kg	O
)	O
,	O
but	O
generates	O
fewer	O
emissions	O
associated	O
with	O
treating	O
complications	O
(	O
3,019	O
kg	O
versus	O
3,337	O
kg	O
)	O
.	O

The	O
insulin	O
-	O
oral	O
antidiabetic	I:C0935929
combination	O
regimen	B:C0040808
generates	O
more	O
treatment	O
and	O
disease	O
management	I:C0376636
-	O
related	O
CO2	O
emissions	O
per	O
patient	O
(	O
1,686	O
kg	O
)	O
than	O
the	O
oral	O
antidiabetic	I:C0935929
-	O
only	O
regimen	O
(	O
310	O
kg	O
)	O
,	O
but	O
generates	O
fewer	O
emissions	O
associated	O
with	O
treating	O
complications	O
(	O
3,019	O
kg	O
versus	O
3,337	O
kg	O
)	O
.	O

The	O
insulin	O
-	O
oral	O
antidiabetic	I:C0935929
combination	O
regimen	O
generates	O
more	O
treatment	O
and	O
disease	B:C0376636
management	I:C0376636
-	O
related	O
CO2	O
emissions	O
per	O
patient	O
(	O
1,686	O
kg	O
)	O
than	O
the	O
oral	O
antidiabetic	I:C0935929
-	O
only	O
regimen	O
(	O
310	O
kg	O
)	O
,	O
but	O
generates	O
fewer	O
emissions	O
associated	O
with	O
treating	O
complications	O
(	O
3,019	O
kg	O
versus	O
3,337	O
kg	O
)	O
.	O

The	O
insulin	O
-	O
oral	O
antidiabetic	I:C0935929
combination	O
regimen	O
generates	O
more	O
treatment	O
and	O
disease	O
management	I:C0376636
-	O
related	O
CO2	B:C0007012
emissions	O
per	O
patient	O
(	O
1,686	O
kg	O
)	O
than	O
the	O
oral	O
antidiabetic	I:C0935929
-	O
only	O
regimen	O
(	O
310	O
kg	O
)	O
,	O
but	O
generates	O
fewer	O
emissions	O
associated	O
with	O
treating	O
complications	O
(	O
3,019	O
kg	O
versus	O
3,337	O
kg	O
)	O
.	O

The	O
insulin	O
-	O
oral	O
antidiabetic	I:C0935929
combination	O
regimen	O
generates	O
more	O
treatment	O
and	O
disease	O
management	I:C0376636
-	O
related	O
CO2	O
emissions	O
per	O
patient	O
(	O
1,686	O
kg	O
)	O
than	O
the	O
oral	B:C0935929
antidiabetic	I:C0935929
-	O
only	O
regimen	O
(	O
310	O
kg	O
)	O
,	O
but	O
generates	O
fewer	O
emissions	O
associated	O
with	O
treating	O
complications	O
(	O
3,019	O
kg	O
versus	O
3,337	O
kg	O
)	O
.	O

The	O
insulin	O
-	O
oral	O
antidiabetic	I:C0935929
combination	O
regimen	O
generates	O
more	O
treatment	O
and	O
disease	O
management	I:C0376636
-	O
related	O
CO2	O
emissions	O
per	O
patient	O
(	O
1,686	O
kg	O
)	O
than	O
the	O
oral	O
antidiabetic	I:C0935929
-	O
only	O
regimen	B:C0040808
(	O
310	O
kg	O
)	O
,	O
but	O
generates	O
fewer	O
emissions	O
associated	O
with	O
treating	O
complications	O
(	O
3,019	O
kg	O
versus	O
3,337	O
kg	O
)	O
.	O

The	O
insulin	O
-	O
oral	O
antidiabetic	I:C0935929
combination	O
regimen	O
generates	O
more	O
treatment	O
and	O
disease	O
management	I:C0376636
-	O
related	O
CO2	O
emissions	O
per	O
patient	O
(	O
1,686	O
kg	O
)	O
than	O
the	O
oral	O
antidiabetic	I:C0935929
-	O
only	O
regimen	O
(	O
310	O
kg	O
)	O
,	O
but	O
generates	O
fewer	O
emissions	O
associated	O
with	O
treating	O
complications	B:C0009566
(	O
3,019	O
kg	O
versus	O
3,337	O
kg	O
)	O
.	O

Overall	O
,	O
adding	O
insulin	B:C0021641
to	O
oral	O
antidiabetic	I:C0935929
therapy	O
generates	O
an	O
extra	O
1,057	O
kg	O
of	O
CO2	O
emissions	O
per	O
patient	O
over	O
30	O
years	O
.	O

Overall	O
,	O
adding	O
insulin	O
to	O
oral	B:C0935929
antidiabetic	I:C0935929
therapy	O
generates	O
an	O
extra	O
1,057	O
kg	O
of	O
CO2	O
emissions	O
per	O
patient	O
over	O
30	O
years	O
.	O

Overall	O
,	O
adding	O
insulin	O
to	O
oral	O
antidiabetic	I:C0935929
therapy	B:C0087111
generates	O
an	O
extra	O
1,057	O
kg	O
of	O
CO2	O
emissions	O
per	O
patient	O
over	O
30	O
years	O
.	O

Overall	O
,	O
adding	O
insulin	O
to	O
oral	O
antidiabetic	I:C0935929
therapy	O
generates	O
an	O
extra	O
1,057	O
kg	O
of	O
CO2	B:C0007012
emissions	O
per	O
patient	O
over	O
30	O
years	O
.	O

The	O
model	O
offers	O
a	O
simple	O
approach	O
for	O
incorporating	O
environmental	B:C0014406
outcomes	O
into	O
health	O
economic	O
analyses	O
,	O
to	O
support	O
a	O
decision	O
-	O
maker	O
's	O
objective	O
of	O
reducing	O
the	O
environmental	O
impact	O
of	O
health	O
care	I:C0086388
.	O

The	O
model	O
offers	O
a	O
simple	O
approach	O
for	O
incorporating	O
environmental	O
outcomes	O
into	O
health	O
economic	O
analyses	O
,	O
to	O
support	O
a	O
decision	O
-	O
maker	O
's	O
objective	O
of	O
reducing	O
the	O
environmental	O
impact	O
of	O
health	B:C0086388
care	I:C0086388
.	O

Further	O
work	O
is	O
required	O
to	O
improve	B:C0184511
the	O
accuracy	O
of	O
the	O
approach	O
;	O
in	O
particular	O
,	O
the	O
generation	O
of	O
resource	O
-	O
specific	O
environmental	O
impacts	O
.	O

